Heart Failure clinical trials in Florida
58 active Heart Failure trials with a site in Florida. Describe your situation to see which ones look like a fit.
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
- TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
- Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Assessment of CCM in HF With Higher Ejection Fraction
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
- His-Bundle Corrective Pacing in Heart Failure
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- Left vs Left Randomized Clinical Trial
- Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
- PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment
- Alleviant ALLAY-HF Study
- Alleviant ALLAY-HFrEF Study
- CCM OPEN HF Registry
- The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)
- AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
- Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
- Cardiogenic Shock Working Group Registry
- Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- Supporting Health in Veterans With Heart Failure
- Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
- Pivotal Trial to Evaluate the Safety and Effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System
- A Study of the Effect of a Nurse Navigator Program on High Risk Patients
- Novel On-body Evaluation of Cardiac Health for Oncology
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.